CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 47 enrolled
Drug / intervention
ProLab 200mg caffeine capsule +3 moredrug
Likely dose
ProLab 200mg caffeine capsulefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02411318
NCT02411318N/ACompleted
CompareCT.gov

Influence of Lifestyle Factors on Neutrophil Migration Pilot Study

University of Wisconsin, Madison·interventional·Posted Apr 8, 2015·Updated Dec 17, 2020

In Brief

A clinical study evaluating Exercise, ProLab 200mg caffeine capsule, and 2 other interventions for Neutrophil Chemotactic Response. Completed, enrolled 47 participants across 1 site.

Detailed Summary

This study will determine how common lifestyle practices affect the behavior of neutrophils (a type of immune cell) at shorter time scales than previously possible.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeutrophil Chemotactic Response
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 8, 2015
Enrollment StartSep 25, 2014
Primary CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 11.2 years ago

Interventions

Exercisebehavioral

Participants will ride a stationary bike and maintain their target heart rate (according to the American Heart Association guidelines) for 30 minutes.

ProLab 200mg caffeine capsuledrug

Participants will swallow one ProLab caffeine 200mg tablet.

Ethanol ingestionother

Participants will consume a dose of 80 proof alcohol according to their body weight to reach a breath alcohol concentration of 0.05.

Glucose Tolerance Drinkdrug

Participants will consume 100 grams of glucose